LeonaBio (LONA) Research & Development (2019 - 2026)

LeonaBio (LONA) has 8 years of Research & Development data on file, last reported at $11.3 million in Q1 2026.

• Research & Development for Q1 2026 came in at $11.3 million, up 161.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.5 million (down 54.49% YoY), and the FY2025 annual result was $17.5 million, down 75.24% from the prior year.
• Research & Development grew to $11.3 million in Q1 2026 per LONA's latest filing, from $6.7 million in the prior quarter.
• Over five years, Research & Development peaked at $27.2 million in Q3 2023 and troughed at $2.8 million in Q3 2025.
• A 5-year average of $15.0 million and a median of $15.2 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2025 and 2026: Research & Development tumbled 84.24% in 2025, then surged 161.79% in 2026.
• A 5-year view of Research & Development shows it stood at $15.2 million in 2022, then jumped by 55.42% to $23.7 million in 2023, then slumped by 60.43% to $9.4 million in 2024, then dropped by 28.37% to $6.7 million in 2025, then jumped by 67.79% to $11.3 million in 2026.
• Business Quant data shows LONA's Research & Development at $11.3 million in Q1 2026, $6.7 million in Q4 2025, and $2.8 million in Q3 2025.